Elanco Animal Health Research and Development Expenses 2016-2025 | ELAN

Elanco Animal Health annual/quarterly research and development expenses history and growth rate from 2016 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Elanco Animal Health research and development expenses for the quarter ending March 31, 2025 were $94M, a 8.05% increase year-over-year.
  • Elanco Animal Health research and development expenses for the twelve months ending March 31, 2025 were $351M, a 5.41% increase year-over-year.
  • Elanco Animal Health annual research and development expenses for 2024 were $0.344B, a 5.2% increase from 2023.
  • Elanco Animal Health annual research and development expenses for 2023 were $0.327B, a 1.87% increase from 2022.
  • Elanco Animal Health annual research and development expenses for 2022 were $0.321B, a 13.01% decline from 2021.
Elanco Animal Health Annual Research and Development Expenses
(Millions of US $)
2024 $344
2023 $327
2022 $321
2021 $369
2020 $329
2019 $270
2018 $247
2017 $252
2016 $266
2015 $291
Elanco Animal Health Quarterly Research and Development Expenses
(Millions of US $)
2025-03-31 $94
2024-12-31 $81
2024-09-30 $87
2024-06-30 $89
2024-03-31 $87
2023-12-31 $79
2023-09-30 $86
2023-06-30 $81
2023-03-31 $81
2022-12-31 $80
2022-09-30 $78
2022-06-30 $82
2022-03-31 $81
2021-12-31 $92
2021-09-30 $94
2021-06-30 $94
2021-03-31 $89
2020-12-31 $115
2020-09-30 $88
2020-06-30 $59
2020-03-31 $67
2019-12-31 $67
2019-09-30 $70
2019-06-30 $69
2019-03-31 $64
2018-12-31 $61
2018-09-30 $59
2018-06-30 $61
2018-03-31 $65
2017-12-31
2017-09-30 $62
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $5.940B $4.439B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.755B 19.47
Encompass Health (EHC) United States $11.734B 24.87
DaVita (DVA) United States $11.050B 14.67
Chemed (CHE) United States $8.342B 26.22
Option Care Health (OPCH) United States $5.214B 23.24
RadNet (RDNT) United States $4.181B 88.48
Amedisys (AMED) United States $3.128B 21.04
LifeStance Health (LFST) United States $2.228B 0.00
Addus HomeCare (ADUS) United States $2.041B 22.41
Astrana Health (ASTH) United States $1.666B 41.26
U.S Physical Therapy (USPH) United States $1.125B 29.05
Aveanna Healthcare Holdings (AVAH) United States $1.054B 60.00
Pennant (PNTG) United States $0.985B 36.18
Atai Life Sciences (ATAI) Germany $0.278B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00